GlassScriptPhysician profile
Rambabu Tummala
NPI 1295716645
$11,452.27
in general payments reported to CMS, 2019-2025
75 companies · $2,735 in 2025
The $2,735 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,025 · 2020: $631 · 2021: $1,299 · 2022: $1,742 · 2023: $1,841 · 2024: $2,179 · 2025: $2,735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,755.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,755.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $883.48 | 2019-2025 | |
| Janssen Biotech, INC. | $715.82 | 2019-2025 | Rybrevant, Darzalex, Erleada |
| Merck Sharp & Dohme LLC | $712.72 | 2019-2025 | Keytruda, Welireg, Lynparza |
| E.R. Squibb & Sons, L.L.C. | $575.01 | 2019-2025 | Opdivo, Augtyro, Opdualag |
| Incyte Corporation | $502.28 | 2019-2025 | Jakafi, Monjuvi, Zynyz |
| Celgene Corporation | $466.16 | 2019-2025 | Reblozyl, Opdualag |
| Pfizer INC. | $430.00 | 2019-2025 | |
| Genzyme Corporation | $426.07 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $415.36 | 2020-2025 | Imfinzi, Enhertu, Calquence |
| Takeda Pharmaceuticals U.S.A., INC. | $396.44 | 2021-2025 | Alunbrig, Fruzaqla, Iclusig |
| Astellas Pharma US INC | $330.98 | 2019-2025 | Vyloy, Padcev, Xospata |
| Eisai INC. | $330.54 | 2021-2025 | |
| Seagen INC. | $289.79 | 2021-2023 | Tukysa, Adcetris |
| Amgen INC. | $285.10 | 2019-2023 | Kyprolis, Blincyto, Nplate |
| Regeneron Healthcare Solutions, INC. | $252.70 | 2019-2025 | Libtayo |
Show all 75 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $249.10 | 2019-2024 | Jaypirca, Verzenio, Retevmo |
| Genentech USA, INC. | $225.66 | 2019-2025 | Tecentriq, Polivy |
| Bayer Healthcare Pharmaceuticals INC. | $223.98 | 2019-2025 | |
| Gilead Sciences, INC. | $216.93 | 2021-2025 | Trodelvy |
| Pharmacyclics LLC, An Abbvie Company | $212.88 | 2021-2023 | Imbruvica |
| Daiichi Sankyo INC. | $207.93 | 2019-2025 | Enhertu, Vanflyta, Datroway |
| Glaxosmithkline, LLC. | $189.82 | 2020-2025 | Ojjaara, Blenrep, Shingrix |
| Beone Medicines USA, INC. | $185.70 | 2025 | Brukinsa, Tevimbra |
| Abbvie INC. | $173.54 | 2022-2025 | |
| Array Biopharma INC | $170.32 | 2019-2025 | Mektovi, Braftovi, Tukysa |
| Emd Serono, INC. | $162.33 | 2019-2025 | Bavencio |
| Foundation Medicine, INC. | $142.12 | 2020-2023 | |
| Sobi, INC | $139.88 | 2022-2024 | |
| Alexion Pharmaceuticals, INC. | $111.45 | 2019-2025 | Ultomiris |
| Tersera Therapeutics LLC | $111.34 | 2022-2024 | Zoladex |
| Pharmacosmos Therapeutics INC. | $103.66 | 2023-2025 | Monoferric, Cosela |
| Kite Pharma, INC. | $102.56 | 2022-2024 | Yescarta |
| Pharmaessentia USA Corporation | $100.13 | 2023-2025 | Besremi |
| Myriad Genetic Laboratories, INC. | $78.20 | 2021 | |
| Geron Corporation | $77.86 | 2025 | Rytelo |
| Beigene USA, INC. | $72.83 | 2022-2024 | Brukinsa |
| Stemline Therapeutics INC. | $67.88 | 2023-2024 | Orserdu, Elzonris |
| Puma Biotechnology, INC. | $66.78 | 2022-2024 | |
| Ipsen Biopharmaceuticals, INC | $60.04 | 2019-2025 | Somatuline Depot, Onivyde |
| Kyowa Kirin, INC. | $59.26 | 2025 | |
| Sun Pharmaceutical Industries INC. | $58.92 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.01 | 2019-2021 | |
| G1 Therapeutics, INC. | $52.73 | 2022-2023 | Cosela |
| Adc Therapeutics America, INC. | $43.71 | 2023-2024 | |
| Amag Pharmaceuticals, INC. | $40.21 | 2019 | |
| Morphosys, US INC. | $40.13 | 2022-2023 | Monjuvi |
| Dova Pharmaceuticals | $39.99 | 2019-2020 | |
| Spectrum Pharmaceuticals INC. | $34.71 | 2023 | Rolvedon |
| Tg Therapeutics, INC. | $33.08 | 2021 | |
| Legend Biotech USA INC. | $30.38 | 2025 | Carvykti |
| Genmab U.S., INC. | $28.92 | 2023 | Epkinly |
| Tesaro, INC. | $28.47 | 2019 | |
| Tolmar, INC. | $26.35 | 2024 | |
| Innate Pharma, INC | $24.21 | 2020 | |
| Azurity Pharmaceuticals, INC. | $23.53 | 2025 | Danziten |
| Tempus Ai, INC | $23.46 | 2024 | Xt Cdx |
| Jazz Pharmaceuticals INC. | $23.42 | 2022 | |
| Servier Pharmaceuticals LLC | $21.88 | 2024 | |
| Syndax Pharmaceuticals, INC. | $21.57 | 2025 | |
| Recordati_rare_diseases_inc. | $20.98 | 2023 | Sylvant |
| Adaptive Biotechnologies Corporation | $20.64 | 2024 | Clonoseq |
| Epizyme, INC. | $20.13 | 2022 | |
| Apellis Pharmaceuticals, INC. | $19.91 | 2022 | |
| Taiho Oncology, INC. | $19.72 | 2022 | |
| Agios Pharmaceuticals, INC. | $18.78 | 2023 | Pyrukynd |
| Rigel Pharmaceuticals, INC. | $18.13 | 2019 | |
| Mirati Therapeutics, INC. | $18.04 | 2023 | Krazati |
| Janssen Pharmaceuticals, INC | $16.40 | 2022 | |
| Ge Healthcare | $16.13 | 2022 | |
| Novocure INC. | $15.88 | 2025 | Optune Lua (Novottf-200t) |
| Exelixis INC. | $15.79 | 2025 | Cabometyx |
| Cti Biopharma Corp. | $14.77 | 2023 | Vonjo |
| Karyopharm Therapeutics INC. | $14.71 | 2022 | |
| Global Blood Therapeutics, INC. | $14.29 | 2020 | |
| Clovis Oncology, INC. | $13.66 | 2019 |
Drugs and devices associated with these payments
Keytruda $493Reblozyl $362Tukysa $249Kisqali $234Enhertu $228Libtayo $224Jakafi $220Lenvima $209Sarclisa $193Brukinsa $190Imfinzi $164Scemblix $154Opdivo $150Ibrance $147Verzenio $142Jaypirca $142Monjuvi $135Ojjaara $118Retevmo $116Venclexta $116Adcetris $111Mektovi $106Braftovi $106Besremi $100Welireg $98.50Pluvicto $95.90Lynparza $89.71Vyloy $86.91Imbruvica $85.96Nubeqa $85.87Zoladex $82.05Monoferric $81.00Opdualag $80.80Tecentriq $80.39Xtandi $79.14Rytelo $77.86Vitrakvi $72.29Stivarga $72.29Fabhalta $72.28Elrexfio $71.96Epkinly $68.36Talzenna $64.39Bosulif $64.35Lutathera $62.10Alunbrig $61.33Rybrevant $59.81Ultomiris $59.60Poteligeo $59.26Trodelvy $57.82Doptelet $56.60Tasigna $54.81Darzalex $54.47Tevimbra $52.41Padcev $49.85Keytruda Qlex $48.29Calquence $47.94Vonjo $45.97Vanflyta $44.29Cosela $42.23Orserdu $41.71Tivdak $41.33Inlyta $40.42Xofigo $38.25Synagis $37.95Kyprolis $37.89Polivy $37.54Lorbrena $37.39Xalkori $37.39Rolvedon $34.71Krazati $34.53Onivyde $31.35Somatuline Depot $31.35Fruzaqla $31.21Carvykti $30.38Erleada $28.47Eligard $26.35Yonsa $26.19Odomzo $26.19Elzonris $26.17Yescarta $24.74Talvey $24.64Orgovyx $23.97Piqray $23.87Promacta $23.84Danziten $23.53Xt Cdx $23.46Iclusig $23.25Datroway $22.47Idhifa $21.88Augtyro $21.53Sylvant $20.98Blenrep $20.91Clonoseq $20.64Mekinist $19.61Pyrukynd $18.78Blincyto $18.51Comirnaty $18.09Xospata $17.87Enjaymo $16.67Paxlovid $16.54
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rambabu Tummala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.